SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-20-039671
Filing Date
2020-08-12
Accepted
2020-08-12 16:05:41
Documents
49
Period of Report
2020-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q nltx-10q_20200630.htm 10-Q 1462549
2 EX-10.1 nltx-ex101_130.htm EX-10.1 41204
3 EX-10.2 nltx-ex102_301.htm EX-10.2 68560
4 EX-31.1 nltx-ex311_8.htm EX-31.1 15671
5 EX-31.2 nltx-ex312_6.htm EX-31.2 15629
6 EX-32.1 nltx-ex321_7.htm EX-32.1 8394
7 GRAPHIC g4cmattrj4wm000001.jpg GRAPHIC 40735
  Complete submission text file 0001564590-20-039671.txt   3935920

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE DOCUMENT nltx-20200630.xml EX-101.INS 560137
9 XBRL TAXONOMY EXTENSION SCHEMA nltx-20200630.xsd EX-101.SCH 27381
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE nltx-20200630_cal.xml EX-101.CAL 24567
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE nltx-20200630_def.xml EX-101.DEF 71075
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE nltx-20200630_lab.xml EX-101.LAB 244518
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE nltx-20200630_pre.xml EX-101.PRE 175681
Mailing Address SUITE 360 - 1616 EASTLAKE AVE EAST SEATTLE WA 98102
Business Address SUITE 360 - 1616 EASTLAKE AVE EAST SEATTLE WA 98102 206-732-2133
Neoleukin Therapeutics, Inc. (Filer) CIK: 0001404644 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36327 | Film No.: 201095489
SIC: 2834 Pharmaceutical Preparations